Prestige Consumer Healthcare (PBH) has issued an update.
John F. Kelly, with an impressive 40-year tenure at Pfizer Inc., has been elected to the board of directors of a company, bringing his vast experience in quality operations and environmental, health, and safety management. Having held significant leadership roles at Pfizer and served as Chairman of Zydus Cadila Oncology, Kelly’s expertise will also be utilized in the company’s Compensation and Talent Management and Nominating and Corporate Governance Committees. His appointment, based on merit and not through any pre-arranged agreements, underscores his value to the board.
Learn more about PBH stock on TipRanks’ Stock Analysis page.
